Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 0.5420
-0.0100 (-1.81%)
Aug 1, 2025, 5:09 PM CET
Intercept Pharmaceuticals Market Cap
Sprint Bioscience AB has a market cap or net worth of 57.19 million as of August 1, 2025. Its market cap has decreased by -36.80% in one year.
Market Cap
57.19M
Enterprise Value
38.40M
Revenue
62.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.54
Market Cap Chart
Since November 7, 2014, Sprint Bioscience AB's market cap has decreased from 62.49M to 57.19M, a decrease of -8.49%. That is a compound annual growth rate of -0.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 57.19M | -48.22% |
| Dec 30, 2024 | 110.46M | -8.82% |
| Dec 29, 2023 | 121.14M | 449.78% |
| Dec 30, 2022 | 22.03M | -88.47% |
| Dec 30, 2021 | 191.05M | 17.26% |
| Dec 30, 2020 | 162.93M | 14.86% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 96.35B |
| Sectra AB | 71.68B |
| Getinge AB | 53.34B |
| Camurus AB | 41.80B |
| Medicover AB | 41.67B |
| Asker Healthcare Group AB | 38.24B |
| Bonesupport Holding AB | 22.17B |
| AddLife AB | 21.05B |